CSI Market
Sign In | Register

Betterlife Pharma Inc (BETR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BETR Annual Cash Flow →
The data below summarizes Betterlife Pharma Inc's cash flow activity from Dec 31 2024 to Dec 31 2025, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Operating Activities
Income-165.87
Depreciation & amortization1.04
Amortization of Other Assets14.73
Accretion Expense0.00
Other Asset Impairment Charges12.51
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.69
Share-based Compensation20.43
Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss0.00
Financial Instruments and Foreign Currency Transaction-4,678.91
Debt Instrument Increase Decrease Other Net-
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease-
Stock Issued During Period Shares Other-
Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued-
Stock Issued During Period Value Share Based Compensation-
Stock Issued During Period Shares Conversion Of Convertible Securities-
Accretion Of Discount On Convertible Debentures Increase Decrease-
Stock Issued For Loan Default-
Shares Issued For Loan Defaults-
Services Contributed By Related Party-
Unrealized Loss On Foreign Currency Derivatives Before Tax-
Accretion Of Discount-
Increase Decrease In Fair Value Adjustments On Assets And Liabilities Carried At Fair Value Under Fair Value Option-
Stock Issued For Financing Costs-
Related Party Transaction Expenses From Transactions With Related Party-
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value-
Interest Accretion-
Lease Expense-
Gain On Repayment Of Promissory Note-
Writeoff Of Equipment-
Exchange Gain Loss-
Income taxes0.00
Adjustments For Gains Losses On Change In Fair Value Of Derivatives-1.27
Increase (Decrease) in Other Receivables2.30
Adjustments For Decrease IncreaseIn Trade Account Receivable17.03
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets9.49
Other Working Capital-3.52
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities4,743.43
Discontinued operations0.00
Net Cash flow from Operating Activities-166.58
Investing Activities
Capital Expenditures-11.23
Sale of Capital Items0.00
Short-term Investments Proceeds-46.36
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans-602.32
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-661.51
Financing Activities
Short-term debt Net167.79
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-111.61
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock29.30
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-235.52
Gain Loss On Foreign Currency Cash Flow Hedge Ineffectiveness-
Payment For Debt Modification-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities714.34
Effect of exchange rate on cash flow-7.50
Discontinued operations0.00
Free Cash Flow-177.80
Total Cash Flow-121.25
4 historic quarters locked

Sign in to unlock the full Betterlife Pharma Inc cash flow history.

Sign In Create Free Account

About Better Home and Finance Holding Co Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-055745

Figures are derived from filed reports and may be restated. Historical data is subject to revision.